Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis - Athyros, Vasilios G; Tziomalos, Konstantinos; Gossios, Thomas D; Griva, Theodora; Anagnostis, Panagiotis; Kargiotis, Konstantinos; Pagourelias, Efstathios D; Theocharidou, Eleni; Karagiannis, Asterios; Mikhailidis, Dimitri P (The Lancet (British edition), 2010)
Keywords: Aged; Atherosclerosis; Biological and medical sciences; Cardiology. Vascular system; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - drug therapy; Coronary Disease - complications; Coronary Disease - drug therapy; Coronary heart disease; Data collection; Diabetes; Fatty Liver - blood; Fatty Liver - complications; Fatty Liver - drug therapy; Female; General aspects; Greece; Heart; Heart failure; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Insulin resistance; Internal Medicine; Liver; Liver Function Tests; Male; Medical sciences; Middle Aged; Mortality; Non-alcoholic Fatty Liver Disease; Prospective Studies; Recurrence; Regression analysis; Risk Reduction Behavior; Statins; Time Factors; Treatment Outcome; Greece; Europe; Human; Evaluation; Digestive system; Enzyme; Toxicity; Treatment efficiency; Liver; Enzyme inhibitor; Exploration; Patient; Cardiovascular disease; Statin derivative; Hypocholesterolemic agent; Coronary heart disease; Long term; Medicine; Treatment; HMG-CoA reductase inhibitor; Atorvastatin; Hydroxymethylglutaryl-CoA reductase; Oxidoreductases; Safety; Greek; Antilipemic agent